Guidelines for Anticoagulation Therapy for Secondary Prevention After Deep Vein Thrombosis

Recurrent VTE by RVT at 3 Months: DACUS Study⁶

June 2011

In this study if you had no residual thrombus, the risk of recurrence was extremely low, and this is how this study was performed.

< Previous Slide

Recurrent VTE by RVT at 3 Months6

Next Slide >

 

Jump to section:

• Introduction
• Independent Risk Factors for Venous Thromboembolism¹
• Thrombophilia Testing
• ACCP Treatment Duration Guidelines²
• Aggressive Thrombophilia²
• Case
• Case
• Recurrence Rate
• ACCP Treatment Duration Guidelines³
• D-Dimer Levels and Risk of Recurrent Venous Thromboembolism⁴
• PROLONG: D-Dimer Testing to Determine Duration of Anticoagulation⁵
• PROLONG: D-Dimer Testing to Determine Duration of Anticoagulation⁵
• Idiopathic VTE
• Residual Vein Thrombosis (RVT) to Assess Optimal Management of DVT: DACUS Study⁶
• Residual Vein Thrombosis (RVT) to Determine Duration of Anticoagulation⁶
• Recurrent VTE by RVT at 3 Months: DACUS Study⁶
• Non-compressed vs. Compressed
• Idiopathic DVT: Take Home Point
• Case (revisited)
• Case (revisited)
• Mortality Risk
• Cumulative Recurrence of DVT vs PE After Incident DVT
• Cumulative Recurrence of DVT vs PE After Incident PE
• Independent Predictors of Death within 7 Days of Venous Thromboembolism Recurrence
• Idiopathic PE – Take Home Points
• References
• Clinical and Laboratory Update in Thrombosis and Anticoagulation
• Questions?